Cloned (Comment) | Organism |
---|---|
PCR-amplification, transfection and expression of CHO cells with FLAG-tagged enzyme cDNA plasmid | Mus musculus |
Protein Variants | Comment | Organism |
---|---|---|
additional information | knockdown of hepatic lysophosphatidylglycerol acyltransferase 1 gene expression in transfected CHO cells by an adenovirus construct of short hairpin RNA (shRNA) | Mus musculus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
shRNA-adenovirus | short hairpin RNA adenovirus construct to knockdown mouse lysophosphatidylglycerol acyltransferase 1, injected via tail vein | Mus musculus |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
43000 | - |
sequence analysis, 370 amino acids | Mus musculus |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
2-acyl-sn-glycerol + acetyl-CoA | Mus musculus | - |
diacylglycerol + CoA | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mus musculus | - |
7 weeks old male diabetic (db/db) and control (db/m) mice, 7 days adjusted | - |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
heart | - |
Mus musculus | - |
intestine | - |
Mus musculus | - |
kidney | - |
Mus musculus | - |
liver | most highly expressed, used for experiments | Mus musculus | - |
skin | - |
Mus musculus | - |
thymus | - |
Mus musculus | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
2-acyl-sn-glycerol + acetyl-CoA | - |
Mus musculus | diacylglycerol + CoA | - |
? | |
2-acyl-sn-glycerol + palmitoyl-CoA | in vitro assay in lysate of transfected CHO cells or of microsome preparation of mouse liver, 2-monoacylglycerol is preferred over 1-monoacylglycerol, 25°C, pH 6.4 | Mus musculus | diacylglycerol + CoA | - |
? | |
additional information | no significant production of phosphatidic acid (substrate lysophosphatidic acid), triacylglycerol (diacylglycerol), or cholesterol ester (substrate cholesterol), 25°C, pH 6.4 | Mus musculus | ? | - |
? | |
rac-1-monoacylglycerol + palmitoyl-CoA | in vitro assay in lysate of transfected CHO cells, 25°C, pH 6.4 | Mus musculus | diacylglycerol + CoA | - |
? |
Synonyms | Comment | Organism |
---|---|---|
acyl-coenzyme A:monoacylglycerol acyltransferase | - |
Mus musculus |
LPGAT1 | two splice isoforms | Mus musculus |
lysophosphatidylglycerol acyltransferase 1 | - |
Mus musculus |
MGAT | - |
Mus musculus |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
additional information | - |
infection with 60000000000 particles per animal (dose limit of no effect of control particles) leads to 83% decreased mRNA levels on day 5, 92% decrease on day 16 post-injection, associated with reduces hepatic MGAT and LPGAT activities (pH 6.4, 25°C), slight body weight reduction despite normal food consumption throughout most of the experimental treatment period (only 15% reduction on day 2), reduced serum triacylglycerols and cholesterol but increased total cholesterol accumulation in the liver | Mus musculus | shRNA-adenovirus |
Organism | Comment | Expression |
---|---|---|
Mus musculus | the infection with a short hairpin RNA-adenovirus construct lowers the lysophosphatidylglycerol acyltransferase 1 expression in diabetic (db/db) mice compared to a control virus infection in a dose-dependent manner, causing a marked reduction in serum triacylglycerol and cholesterol levels, and a significant increase in hepatic cholesterol levels | down |
Mus musculus | hepatic LPGAT1 expression in diabetic (db/db) mice is 2fold higher than in control (db/m), consistent with 1.5fold higher hepatic monoacylglycerol acyltransferase activity | up |
General Information | Comment | Organism |
---|---|---|
metabolism | significant role in hepatic triacylglycerol synthesis and secretion in diabetic mice (db/db) | Mus musculus |